Viewing nowMontesco Chewable Tablet 5mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201501929 · Approved 2015.04.09 · Insurance code 629700460
Prevention of asthma and relief of allergic rhinitis symptoms
This medication helps to prevent and treat asthma continuously. Additionally, it alleviates symptoms of allergic rhinitis that occur seasonally or year-round. Therefore, it is effectively used for the management of respiratory-related allergic diseases.
Adults and adolescents aged 15 years and older: Montelukast is administered orally once daily at a dose of 10 mg. 10 mg orally disintegrating film: 10 mg is placed on the tongue to dissolve without water once daily. Administration should be before meals for 1 hour or 2 hours after meals.
Children aged 6 to 14 years: Chew 5 mg of montelukast once daily or place on the tongue to dissolve without water. 5 mg dry syrup: 5 mg is administered orally once daily.
This medicine contains the artificial sweetener aspartame, which is metabolized into phenylalanine in the body. Therefore, patients with phenylketonuria, a genetic condition that requires restriction of phenylalanine intake, should not take this medication. The amount of aspartame included in this medication is adjusted not to exceed the WHO recommended amount, and there is a maximum daily dosage set for adults. Patients who have hypersensitivity to this medication, lactose intolerance, lactose deficiency, or glucose-galactose malabsorption should also avoid this medication. This medicine is not intended for use during an acute asthma attack; appropriate emergency medication should always be kept on hand. Additionally, inhaled or oral corticosteroids should not be abruptly replaced with this medication. Do not use this medication alone to treat exercise-induced bronchoconstriction, and continue to use inhaled beta agonists as needed. Patients with aspirin hypersensitivity should avoid taking aspirin or non-steroidal anti-inflammatory drugs while using this medication, and it is uncertain whether this medication can treat bronchoconstriction caused by those drugs. During the use of this medication, there are rare occurrences of systemic eosinophilia and vasculitis symptoms, so if these symptoms occur, immediate medical attention is required. No significant drug interactions have been reported when this medication is taken alongside other asthma treatments or multiple medications, but observation by a doctor may be necessary when used with certain enzyme inducers. Women who are pregnant or breastfeeding should consult with a physician before taking this medication, and it should be administered only when necessary. Safety and efficacy have been established in pediatric patients; however, safety has not been established in infants under 6 months of age. In case of overdose, there is no specific antidote, so general symptomatic treatment and clinical observation are necessary. This medication is light-sensitive, so packaging should not be opened until just before use, and it should be taken as soon as possible after opening. It is important to keep this medication out of reach of children and not transfer it to other containers. This medication should be taken consistently even when asthma symptoms are not present, and if symptoms worsen, consultation with a doctor is necessary. Report any neuropsychiatric symptoms that occur during use immediately.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, anaphylaxis, cold sweat, pallor, severe allergic reaction, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice, liver abnormalities (jaundice), sudden
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is advised to keep it away from direct sunlight and store it at room temperature between 1 to 30 degrees Celsius. This way, the efficacy of the medication can be maintained for a longer time.
Pink chewable tablets that are round and biconvex on both sides
28T (7T/ PTP packaging X 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.